STK11 and metabolic dysfunction-associated steatotic liver disease: Activation of the LKB1/AMPK pathway by terpenoids inhibits fatty acid synthesis, enhances mitochondrial β‐oxidation, and reduces lipase expression, improving non‐alcoholic steatohepatitis (NASH) and preventing NAFLD progression (Omidkhoda et al. 2023).